HealthStream, Inc. (HSTM)
NASDAQ: HSTM · Real-Time Price · USD
27.45
-0.39 (-1.40%)
At close: May 12, 2025, 4:00 PM
27.45
0.00 (0.00%)
After-hours: May 12, 2025, 5:44 PM EDT
HealthStream Market Cap
HealthStream has a market cap or net worth of $837.92 million as of May 12, 2025. Its market cap has increased by 6.69% in one year.
Market Cap
837.92M
Enterprise Value
740.32M
1-Year Change
6.69%
Ranking
Category
Stock Price
$27.45
Market Cap Chart
Since April 11, 2000, HealthStream's market cap has increased from $165.60M to $837.92M, an increase of 405.99%. That is a compound annual growth rate of 6.67%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 9, 2025 | 849.80M | -12.14% |
Dec 31, 2024 | 967.20M | 18.15% |
Dec 29, 2023 | 818.60M | 7.80% |
Dec 30, 2022 | 759.40M | -8.73% |
Dec 31, 2021 | 832.00M | 20.27% |
Dec 31, 2020 | 691.80M | -21.45% |
Dec 31, 2019 | 880.70M | 12.81% |
Dec 31, 2018 | 780.70M | 5.69% |
Dec 29, 2017 | 738.70M | -7.09% |
Dec 30, 2016 | 795.10M | 14.21% |
Dec 31, 2015 | 696.20M | -14.55% |
Dec 31, 2014 | 814.70M | -8.39% |
Dec 31, 2013 | 889.30M | 39.76% |
Dec 31, 2012 | 636.30M | 55.27% |
Dec 30, 2011 | 409.80M | 133.77% |
Dec 31, 2010 | 175.30M | 105.75% |
Dec 31, 2009 | 85.20M | 71.08% |
Dec 31, 2008 | 49.80M | -36.24% |
Dec 31, 2007 | 78.10M | -9.82% |
Dec 29, 2006 | 86.60M | 72.17% |
Dec 30, 2005 | 50.30M | -9.21% |
Dec 31, 2004 | 55.40M | 4.14% |
Dec 31, 2003 | 53.20M | 85.37% |
Dec 31, 2002 | 28.70M | 28.13% |
Dec 31, 2001 | 22.40M | 5.66% |
View and export this data all the way back to 2000.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 659.45B |
Johnson & Johnson | 371.06B |
UnitedHealth Group | 345.29B |
AbbVie | 326.08B |
Novo Nordisk | 297.79B |
Abbott Laboratories | 231.82B |
Novartis AG | 214.71B |
AstraZeneca | 211.14B |